$48.56
-3.22 (-6.21%)
Performance
1D
—
1W
-5.56%
1M
-7.24%
3M
-9.25%
6M
-10.09%
1Y
-14.22%
YTD
-9.69%
Open$51.01
Previous Close$51.78
Day High$51.21
Day Low$47.76
52W High$65.98
52W Low$44.12
Volume—
Avg Volume1.35M
Market Cap4.94B
P/E Ratio—
EPS$-4.76
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$53.67
Below
SMA 200
$52.84
Below
RSI (14)
50.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
28 analysts
Price Target
+128.7% upside
Current
$48.56
$48.56
Target
$111.08
$111.08
$83.97
$111.08 avg
$162.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.55M | 2.48M | 1.10B |
| Net Income | -589,192,914 | -370,794,785 | -133,819,624 |
| Profit Margin | -16,569.8% | -15,741.3% | -12.2% |
| EBITDA | -653,518,030 | -434,124,976 | -179,167,841 |
| Free Cash Flow | — | — | -115,939,335 |
| Rev Growth | +43.0% | +43.0% | +24.0% |
| Debt/Equity | — | — | 0.61 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |